Ignite Creation Date:
2024-07-17 @ 11:57 AM
Last Modification Date:
2024-10-26 @ 3:34 PM
Study NCT ID:
NCT06499688
Status:
COMPLETED
Last Update Posted:
2024-07-12
First Post:
2024-07-07
Brief Title:
A Phase III Study to Evaluate the Efficacy and Safety of Recombinant Botulinum Toxin Type A for Injection in the Treatment of Moderate to Severe Glabellar Lines
Sponsor:
Chongqing Claruvis Pharmaceutical Co Ltd
Organization:
Chongqing Claruvis Pharmaceutical Co Ltd
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-12-28
Start Date Type:
ACTUAL
Primary Completion Date:
2024-03-29
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-05-31
Completion Date Type:
ACTUAL
First Submit Date:
2024-07-07
First Submit QC Date:
None
Study First Post Date:
2024-07-12
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-07-23
Last Update Post Date:
2024-07-12
Last Update Post Date Type:
ACTUAL